Ipamorelin

What it is

Ipamorelin is a synthetic peptide that belongs to the class of Growth Hormone Secretagogues (GHS). It was developed to mimic the effects of ghrelin, a hormone produced in the gut that signals the brain to release growth hormone. We consider it a "third-generation" GHS because it is much more selective than its predecessors, like GHRP-2 or GHRP-6.

Unlike older versions, Ipamorelin is designed to target only the growth hormone release. It doesn't typically trigger the release of other hormones like cortisol (the stress hormone) or prolactin, which makes it a popular choice for research looking for a cleaner, more controlled hormonal response.

What it does

Ipamorelin works by binding to the ghrelin receptors in the pituitary gland. This "pulses" the gland to release your own stored growth hormone into the bloodstream. Because it mimics a natural rhythm, it doesn't shut down the body's natural production, which is a significant concern with synthetic HGH injections.

Researchers and users often explore Ipamorelin for its potential to improve sleep quality, support fat loss, and enhance muscle recovery. Because it doesn't typically cause a sharp increase in appetite (a common side effect of other ghrelin mimetics), it is often used by those who want the benefits of growth hormone without the struggle of constant hunger.

What the evidence says

Ipamorelin has a relatively long history of clinical research compared to other peptides. It was originally studied for its potential to help patients recover from bowel surgery by stimulating gut motility. While those specific clinical trials were discontinued for business reasons rather than safety concerns, they provided a good baseline for understanding how the human body reacts to the peptide.

The evidence suggests that Ipamorelin is effective at increasing plasma growth hormone levels in a dose-dependent manner. However, most of the "anti-aging" or "body composition" benefits that users report are based on small pilot studies or anecdotal evidence from the wellness community rather than large-scale FDA trials.

What it costs

Ipamorelin is frequently sold in 2mg or 5mg vials. A single 5mg vial usually costs between $40 and $65 in the US. Depending on the research protocol, a typical monthly cost for an individual usually falls between $120 and $250.

Side effects and risks

The side effect profile for Ipamorelin is generally considered mild. Users report temporary flushing, a slight tingling in the hands or feet, or a mild headache. Because it can influence insulin sensitivity over the long term, we note that it should be monitored carefully in research subjects with a history of blood sugar issues.

Ipamorelin was previously removed from the FDA's Category 2 list and reviewed by the PCAC in October 2024 (rejected for 503A inclusion). It was not part of the April 2026 expanded reevaluation, so its compounding status remains restricted as of April 2026.

Where users source it

Most users find Ipamorelin through research peptide vendors. Quality is the biggest hurdle in this space; we recommend checking for "purity reports" and ensuring the product is kept lyophilized (freeze-dried) and cold-shipped to maintain the delicate structure of the peptide.

Sources

• Raun K, et al. (1998). "Ipamorelin, the first selective growth hormone secretagogue." European Journal of Endocrinology. PMID 9801863
• Gobburu JV, et al. (1999). "Pharmacokinetics and pharmacodynamics of ipamorelin." Pharmaceutical Research. PMID 10451433
• ProPublica. (April 2026). "An FDA Reversal on Peptides..."